RA
RXST icon

Royce & Associates’s RxSight RXST Stock Holding History

Royce & Associates’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,402
Closed -$2.34M – 890
2024
Q3 		$2.34M Sell
47,402
-42,020
-47% -$2.15M 0.02% 597
2024
Q2 		$5.38M Buy
89,422
+25,028
+39% +$1.43M 0.05% 463
2024
Q1 		$3.32M Buy
+64,394
New +$3.16M 0.03% 560

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Royce & Associates's RXST Position: Q4 2024 in Review

Royce & Associates sold out of RxSight (RXST) in Q4 2024, closing a stake of 47,402 shares — an estimated $2.34M sold.

Royce & Associates first reported a position in RXST in Q1 2024 and held it in 3 quarters. The position peaked at $5.38M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Royce & Associates reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Royce & Associates sold 47,402 RxSight shares in Q4 2024, an estimated $2.34M.
  • Royce & Associates first reported a position in RxSight in Q1 2024 and held it in 3 quarters.
  • Royce & Associates's RxSight position peaked at $5.38M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.